Literature DB >> 21663989

Single vocal cord irradiation: a competitive treatment strategy in early glottic cancer.

Peter C Levendag1, David N Teguh, Fatma Keskin-Cambay, Abrahim Al-Mamgani, Peter van Rooij, Eleftheria Astreinidou, Stefan L S Kwa, Ben Heijmen, Dominique A Monserez, Sarah O S Osman.   

Abstract

INTRODUCTION: The treatment of choice for early glottic cancer is still being debated; ultimately it relies on the functional outcome. This paper reports on a novel sparing 4D conformal technique for single vocal cord irradiation (SVCI).
MATERIAL AND METHODS: The records of 164 T1a patients with SCC of the vocal cord, irradiated in the Erasmus MC between 2000 and 2008, were analyzed for local control and overall survival. The quality of life was determined by EORTC H&N35 questionnaires. Also the VHI (voice handicap index), and the TSH (thyroid stimulating hormone) blood levels, were established. On-line image guided SVCI, using cone beam CT or stereotactic radiation therapy (SRT) techniques, were developed.
RESULTS: A LC rate at five-years of 93% and a VHI of 12.7 (0-63) was determined. It appeared feasible to irradiate one vocal cord within 1-2mm accuracy. This way sparing of the contralateral (CL) vocal cord and CL normal tissues, could be achieved.
CONCLUSIONS: Given the accuracy (1-2mm) and small volume disease (CTV limited to one vocal cord), for the use of stereotactic RT techniques SVCI with large fraction sizes is currently being investigated in clinic. It is argued that hypofractionated SVCI can be a competitive alternative to laser surgery.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21663989     DOI: 10.1016/j.radonc.2011.05.026

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  12 in total

1.  Carotid sparing intensity-modulated radiation therapy achieves comparable locoregional control to conventional radiotherapy in T1-2N0 laryngeal carcinoma.

Authors:  Zachary S Zumsteg; Nadeem Riaz; Sana Jaffery; Man Hu; Daphna Gelblum; Ying Zhou; Borys Mychalczak; Michael J Zelefsky; Suzanne Wolden; Shyam Rao; Nancy Y Lee
Journal:  Oral Oncol       Date:  2015-05-07       Impact factor: 5.337

2.  Comparison of Voice Quality and Cost Effectiveness of Endoscopic Cordectomy Using Microdissection Electrodes with Laser Cordectomy and Radiotherapy.

Authors:  Mehmet Sürmeli; Cağatay Oysu; Ayşe Aslı Şahin Yılmaz; İldem Deveci; Burak Karabulut; Ahmet Volkan Sunter; Özgür Yiğit; Beyhan Ceylaner Bıcakçı
Journal:  Turk Arch Otorhinolaryngol       Date:  2019-03-01

3.  Volumetric modulated arc radiotherapy of the whole larynx, followed by a single affected vocal cord, for T1a glottic cancer: Dosimetric analysis of a case.

Authors:  Seung-Gu Yeo
Journal:  Mol Clin Oncol       Date:  2016-01-14

4.  Definitive radiotherapy for T1 glottic squamous cell carcinoma: a 15-year Cruces University Hospital experience.

Authors:  J Cacicedo; F Casquero; O del Hoyo; A Gomez-Iturriaga; L Martinez-Indart; J L Lopez; P Bilbao
Journal:  Clin Transl Oncol       Date:  2013-03-22       Impact factor: 3.405

5.  Embryonal Rhabdomyosarcoma of the Adult's Vocal Cord: A Case Report.

Authors:  Yining Li; Zhongying Fu; Weilun Chen; Lixin Yang; Wei Zhu
Journal:  Iran Red Crescent Med J       Date:  2015-08-26       Impact factor: 0.611

6.  Long-Term Outcome of Definitive Radiotherapy for Early Glottic Cancer: Prognostic Factors and Patterns of Local Failure.

Authors:  Yu Jin Lim; Hong-Gyun Wu; Tack-Kyun Kwon; J Hun Hah; Myung-Whun Sung; Kwang Hyun Kim; Charn Il Park
Journal:  Cancer Res Treat       Date:  2015-02-13       Impact factor: 4.679

7.  Estimation of daily interfractional larynx residual setup error after isocentric alignment for head and neck radiotherapy: quality assurance implications for target volume and organs-at-risk margination using daily CT on- rails imaging.

Authors:  Charles A Baron; Musaddiq J Awan; Abdallah S R Mohamed; Imad Akel; David I Rosenthal; G Brandon Gunn; Adam S Garden; Brandon A Dyer; Laurence Court; Parag R Sevak; Esengul Kocak-Uzel; Clifton D Fuller
Journal:  J Appl Clin Med Phys       Date:  2014-01-08       Impact factor: 2.102

8.  Dose de-escalation to the normal larynx using conformal radiotherapy reduces toxicity while maintaining oncologic outcome for T1/T2 glottic cancer.

Authors:  Jun Won Kim; Hyung Kwon Byeon; Hong-Shik Choi; Ik Jae Lee
Journal:  Sci Rep       Date:  2017-11-16       Impact factor: 4.379

9.  Dose-Volume Comparison of IMRT and PSPT Treatment Plans for Early-Stage Glottic Cancer.

Authors:  Takahiro Kato; Nobukazu Fuwa; Masao Murakami
Journal:  Int J Part Ther       Date:  2020-11-23

10.  Carotid-Sparing TomoHelical 3-Dimensional Conformal Radiotherapy for Early Glottic Cancer.

Authors:  Chae-Seon Hong; Dongryul Oh; Sang Gyu Ju; Yong Chan Ahn; Jae Myoung Noh; Kwangzoo Chung; Jin Sung Kim; Tae-Suk Suh
Journal:  Cancer Res Treat       Date:  2015-03-06       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.